These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31495292)

  • 81. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
    DeFronzo RA; Buse JB; Kim T; Burns C; Skare S; Baron A; Fineman M
    Diabetologia; 2016 Aug; 59(8):1645-54. PubMed ID: 27216492
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial.
    Hong JGS; Tan PC; Kamarudin M; Omar SZ
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):138. PubMed ID: 33588801
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of postmeal exercise on postprandial glucose excursions in people with type 2 diabetes treated with add-on hypoglycemic agents.
    Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
    Diabetes Res Clin Pract; 2017 Apr; 126():240-247. PubMed ID: 28284168
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
    Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
    Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review.
    Bouland C; Vanden Eynden X; Lalmand M; Buset T; Yanni A; Javadian R; Rodriguez A; Loeb I; Lechien JR; Journe F; Saussez S; Dequanter D
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834839
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers.
    Ochola LA; Nyamu DG; Guantai EM; Weru IW
    J Oncol Pharm Pract; 2020 Jun; 26(4):823-834. PubMed ID: 31495292
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The effect of metformin on glucose metabolism in patients receiving glucocorticoids.
    Landis D; Sutter A; Fernandez F; Nugent K
    Am J Med Sci; 2022 Oct; 364(4):379-385. PubMed ID: 35525318
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Metformin as a therapeutic tool for resistant hematological malignancies: a literature review.
    Paz GS; Fernandes J
    Chin Clin Oncol; 2024 Jun; 13(3):39. PubMed ID: 38859606
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
    Amengual-Cladera E; Morla-Barcelo PM; Morán-Costoya A; Sastre-Serra J; Pons DG; Valle A; Roca P; Nadal-Serrano M
    Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785784
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Metformin: A Novel Weapon Against Inflammation.
    Bai B; Chen H
    Front Pharmacol; 2021; 12():622262. PubMed ID: 33584319
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.